Related Experiment Video
Updated: Jun 12, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Protease-activated receptor-2 (PAR(2)) in human periodontitis
M Holzhausen1, J R Cortelli, V Araújo da Silva
1Division of Periodontics, Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, SP, Avenida Prof. Lineu Prestes, 2227, Cidade Universitária, São Paulo-SP, CEP: 05508-000, Brazil. marinella@usp.br
Protease-activated receptor-2 (PAR(2)) mRNA expression and its activators are elevated in chronic periodontitis. This suggests PAR(2) plays a role in periodontal inflammation, with levels decreasing after treatment.
Area of Science:
- Oral biology
- Immunology
- Periodontology
Background:
- Protease-activated receptor-2 (PAR(2)) role in human periodontal disease remains unclear.
- Chronic periodontitis involves complex inflammatory processes and microbial challenges.
Purpose of the Study:
- Investigate PAR(2) mRNA expression in chronic periodontitis.
- Determine the relationship between PAR(2) expression and its potential activators.
- Assess the impact of periodontal treatment on PAR(2) expression.
Main Methods:
- Collected microbiological and gingival crevicular fluid samples from chronic periodontitis patients and controls.
- Evaluated the presence of neutrophil serine proteinase 3 (P3) and Porphyromonas gingivalis.
- Quantified PAR(2) mRNA expression and levels of inflammatory cytokines (IL-1α, IL-6, IL-8, TNF-α).
Main Results:
- Significantly higher PAR(2) mRNA expression in chronic periodontitis patients compared to controls (p < 0.001).
- Elevated levels of IL-1α, IL-6, IL-8, TNF-α, proteolytic activity, P. gingivalis, and P3 mRNA in periodontitis patients (p < 0.05).
- PAR(2) mRNA expression decreased significantly after periodontal treatment (p = 0.0006).
Conclusions:
- PAR(2) mRNA expression and its activators are elevated in human chronic periodontitis.
- Findings suggest a potential role for PAR(2) in mediating periodontal inflammation.
- Periodontal treatment may reduce PAR(2) expression, indicating its involvement in the disease process.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
IP3/DAG Signaling Pathway
MAPK Signaling Cascades
